cover image: Financial Section of our Annual Report

20.500.12592/5j804s

Financial Section of our Annual Report

28 Jun 2019

ACCOUNTING PRINCIPLES APPLIED IN THE PREPARATION OF THE FINANCIAL STATEMENTS a) Basis of preparation The following exchange rates were used at year end: and retaining the majority of the residual or The consolidated financial statements have 2018 ownership risks related to the SPE or its assets. [...] at the foreign exchange rate ruling on the date evaluation of the substance of its relationship The estimates and associated assumptions are of the transaction. [...] If in the future, such that are measured in terms of historical cost of the benefits related to the SPE’s operations estimates and assumptions, which are based on in a foreign currency are translated using the and net assets, while being exposed to the management’s best judgement at the date of the exchange rate on the date of the transaction. [...] GSK has agreed from GSK, in 2018 MMV received the following regulatory approval, under priority review, to reimburse 50% of MMV cumulative costs revenue from partnerships: from Takeda in of single-dose Krintafel for the radical cure from 2008 until 31 December 2018 in Q1 2019, respect of the co-development of DSM265 for a (prevention of relapse) of Plasmodium vivax 25% in July 2022 and the residua. [...] of the co-development of P218 for a total of Under US law, following approval by the FDA USD 531,989 (2017: USD 389,560); and from of a treatment for a neglected or rare paediatric The cumulative costs incurred by MMV on Shin Poong as refund of the Pyramax® FDA disease, the developer may receive a Priority the development of Krintafel from 2008 to 31 registration costs for a total of USD 445,697 R.
Pages
14
Published in
Switzerland

Tables

All